Receptor tyrosine kinase ERBB4 mediates acquired resistance to ERBB2 inhibitors in breast cancer cells

Approximately 25% of breast cancers overexpress and depend on the receptor tyrosine kinase ERBB2, one of 4 ERBB family members. Targeted therapies directed against ERBB2 have been developed and used clinically, but many patients continue to develop resistance to such therapies. Although much effort...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Cell Cycle
Главные авторы: Canfield, Kaleigh, Li, Jiaqi, Wilkins, Owen M., Morrison, Meghan M, Ung, Matthew, Wells, Wendy, Williams, Charlotte R., Liby, Karen T, Vullhorst, Detlef, Buonanno, Andres, Hu, Huizhong, Schiff, Rachel, Cook, Rebecca S, Kurokawa, Manabu
Формат: Artigo
Язык:Inglês
Опубликовано: Taylor & Francis 2015
Предметы:
Reports
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4614407/
https://ncbi.nlm.nih.gov/pubmed/25590338
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/15384101.2014.994966
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы